Delineating Areas of Secondary Hyperalgesia: Influence of the Assessment Method
NCT ID: NCT02286037
Last Updated: 2014-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
23 participants
OBSERVATIONAL
2013-08-31
2013-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
One of the applications of polyamide monofilaments are the assessments of magnitude of secondary hyperalgesia areas (SHAs), i.e. areas in normal skin near an injury with increased mechanical sensitivity.
The objective of the study is to investigate the hypothesis, based on previous studies, that a light tactile stimulus delineates a larger SHA than stimulation with a more rigid monofilament.
Twenty-three healthy participants were included in this randomized, two-observer, test-retest study.
A highly significant positive correlation between the bending force of the polyamide filaments and the magnitude of SHA was demonstrated. The "weighted-pin" instrument showed significantly and consistently larger areas than the polyamide monofilaments.
The hypothesis was rejected: a light tactile stimulus did not delineate a larger secondary hyperalgesia area than stimulation with a more rigid monofilament. The "weighted-pin" instrument seems an alternative to the conventional polyamide monofilaments.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Method Twenty-three healthy participants were included in this randomized, two-observer, test-retest study. The volunteers were blinded to the test-results. The design was adjusted to examine intra-/inter-observer and intra-/inter-day variability in SHAs after a first degree burn injury was induced by a contact thermode (47ºC, 7 minutes, thermode area 12.5 cm2) on the lower leg. The SHAs were assessed 45 to 75 min (15 min for each observer) after the burn injury and delineated by 3 different polyamide monofilaments (50, 299, 986 mN) and a "weighted-pin" instrument (512 mN). The testing order of the monofilaments was randomized, and the observers were blinded to the study results of each other. The examination order of the observers on Day 1 was reversed on Day 2 (\> 6 weeks later).
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age ≥18 years and ≤ 35 years
* Written informed consent
* Urine sample without any trace of opioids (morphine, methadone, buprenorphin)
* Body Mass Index: 18 \< BMI \< 32 kg/cm2
Exclusion Criteria
* Inability to understand Danish or English
* Participated in another study in the preceding 60 days
* Known neurological disease
* Use of psychoactive drugs (benzodiazepines, SSRI, TCA, SNRI)
* Alcohol or drug abuse
* Chronic pain
* Use of pain medication on a regular basis
* Skin lesions in the examination area
* Use of prescription medicine 1 week before examination
* Use of over-the-counter (OTC) drugs 48 hours before examination
* Smoker
18 Years
35 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Thomas Ringsted
Cand. Scient. San.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Thomas K Ringsted, Nurse,cand.
Role: PRINCIPAL_INVESTIGATOR
Rigshospitalet, Denmark
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
H1-2013-045
Identifier Type: -
Identifier Source: org_study_id